dothelial cells by enhancing the avidity of PMN cell-surface adhesion molecules for endothelial ligands (for review see references [5] [6] [7] [8] . Initial adhesion appears to be supported by interaction of PMN or endothelial cell selectins with carbohydratecontaining counterreceptors. Selectin-mediated adhesion, which is relatively resistant to shear stress, tethers PMNs, causes them to roll on endothelium, and facilitates their immobilization by engagement of PMN CD11/CD 18 82 integrins with endothelial cell ligands such as intercellular adhesion molecule-1 (ICAM-1).' Adhesion of PMNs through CDl 1/CD 18 is essential for normal PMN trafficking and host defense (for review see reference 5) , and also may promote tissue injury in inflammation by priming PMN oxidative bursts and degranulation responses (9, 10) and by promoting the transcellular biosynthesis of lipid mediators during cell-cell interactions ( 11) .
Leukotrienes are generated by the initial actions of 5-lipoxygenase on arachidonic acid and serve as mediators of inflammation in vitro and in vivo (for review see references 12, 13) . Leukotriene B4 (LTB4), in particular, is a potent stimulus for PMN chemotaxis and CD 1 /CD18-mediated PMN-endothelial cell adhesion. Inhibitors of LTB4 biosynthesis attenuate injury in many leukocyte-dependent diseases ( 13) . The potential roles of lipoxygenase-derived products as inhibitors of PMN trafficking are less well defined. 15(S)-hydroxy-5,8,1 1-cis-13-trans-eicosatetraenoic acid ( 15 [S]-HETE) is a potential candidate in this regard (14) (15) (16) (17) (18) (19) (20) (21) (22) . 15-HETE is generated from unesterified sources of arachidonic acid by a variety of mammalian cells including PMNs, endothelial cells, and some epithelial cells via reactions catalysed by 1 5-lipoxygenases, cyclooxygenases, and/or cytochrome P-450 epoxygenases (for review see reference 16). 1 5-HETE has been detected in submicromolar concentrations in sera of normal human blood and in higher concentrations after cell activation (17) . 15-HETE levels are increased in tissues and exudates in a variety of experimental and human diseases including asthma (18) , arthritis ( 19) , and psoriasis (20) . Furthermore, administration ofexogenous 15 (S)-HETE reduces tissue injury in human psoriasis vulgaris (21 ) and carrageenan-induced experimental arthritis (22) . The mechanism by which 15(S)-HETE attenuates tissue injury under these circumstances is not completely understood. Recently it was shown that extracellular 15(S)-HETE is esterified rapidly and stored in phospholipids of PMNs for later use ( 14) . In this study, we assessed the influence of 15 (S)-HETE remodeling of PMN phospholipids on LTB4-induced migration of PMNs across monolayers of hu-man umbilical vein endothelial cells (HUVEC) as an in vitro model of PMN trafficking during acute inflammation.
Methods PMN isolation and labeling with "'In. PMNs were isolated at 4VC from heparinized venous blood drawn from normal volunteers by standard procedures of Ficoll-Hypaque (Organon Teknika Corp., Durham, NC) density gradient centrifugation and dextran sedimentation, as described previously (1 1, 23) . Contaminating red blood cells were removed by hypotonic lysis. The final pellet was suspended in Dulbecco's PBS, pH 7.4, and contained 96±3% PMNs, as determined by light microscopy. Suspensions in which PMNs showed signs ofcellular activation (> 10% of PMNs in clumps of two or more cells) or loss of membrane integrity (< 97% of PMNs excluding trypan blue) were routinely discarded. For studies of transmigration and adhesion, PMNs were radiolabeled with "'In oxine (1 MCi/ 106 cells; Amersham Corp., Mediphysics, Arlington Heights, IL) for 30 min at room temperature, were washed three times in PBS to remove extracellular "'In oxine, and were resuspended in PBS/ 1% bovine calf serum (BCS).
Expression of CDJJ/CD18. PMNs (5 X 106) were fixed by the addition of 2 vol of ice cold PBS/ 1% paraformaldehyde and were kept overnight at 4VC. After washing with ice cold PBS, fixed PMNs were incubated with saturating concentrations of anti-CD18 monoclonal antibody (R15.7, 10 Mg/ml) at 4VC for 30 min followed by FITC-conjugated goat F(ab')2-anti-mouse IgG (Caltag Laboratories, San Francisco, CA) at 4VC for 30 min. After a final washing with ice cold PBS, CD 11/CD 18 expression was assessed in a fluorescence-activated cell sorter (Epics 750; Coulter Electronics Inc., Hialeah, FL).
Right angle light scattering. The scattering intensity of 2.5 x 106 PMNs in PBS was determined at room temperature with a fluorescence spectrophotometer (LS-50; Perkin-Elmer Corp., Norwalk, CT) at a wavelength of 340 nM. Cells were incubated for 5 min with gentle stirring (low setting) in a quartz cuvette with 1-cm path length before addition of LTB4 ( 10-M). For each sample, scattering intensity was normalized to that of the baseline before addition of LTB4.
F-actin content. The relative amounts of F-actin in PMNs before and after addition of LTB4 were determined by quantitating the amount of rhodamine-phalloidin bound to fixed extracted cells by slight modification of a previously described technique (24) . Specifically, 5 x 106 cells/ml were incubated with stirring at room temperature. 200-,ul aliquots were removed at various times before and after addition of l0'-M LTB4 and were added to 200 ,u of 7% formaldehyde, 0.1% TX-100, and 0.1 M rhodamine-phalloidin (Sigma Chemical Co., St. Louis, MO) in TBS, pH 7.8. Cells were fixed overnight at 4°C in the dark, were washed twice with TBS, and were extracted twice with 1 ml MeOH. Extracted rhodamine-phalloidin was quantitated with a fluorescence spectrophotometer (LS-5a; Perkin-Elmer Corp.) with excitation and emission wavelengths of 540 and 570 nM, respectively. The fluorescence intensity of each sample was measured three times, and the results presented are the average of three experiments.
Human umbilical vein endothelial cells. HUVEC were isolated and propagated as described previously (25). Briefly, cells were dispersed by 0.1% collagenase (CLS 3; Worthington Biochemical Corp., Freehold, NJ) and were propagated in cell culture medium (RPMI 1640; BioWhittaker Inc., Walkersville, MD) supplemented with 15% BCS (Hyclone Laboratories, Logan, UT), 15% NU-serum (Collaborative Research Inc., Lexington, MA), 50 Mg/ml endothelial mitogen (Biomedical Technologies, Inc., Stoughton, MA), 8 U/ml heparin, 50 U/ ml penicillin, and 50 Mg/ml streptomycin (HUVEC medium). HU-VEC were characterized based on morphological criteria and by indirect immunofluorescence using a specific antiserum to human Factor VIII antigen, and were studied at passage levels 2 PMNs that migrated to the abluminal compartment was calculated by lysing cells with 0.5% Triton X-100, measuring the radioactivity with a gamma counter (Clinigamma; LKB Instruments, Inc., Gaithersburg, MD), and comparing counts to the specific activity of the original PMN suspension. Unless stated otherwise, results are expressed as the percentage of "'In-labeled PMNs added to the luminal compartment that migrated to the abluminal compartment. LTB4-induced transmigration was calculated by subtraction oftransmigration observed in the presence of diluent.
PMN adhesion to HUVEC monolayers. For studies of adhesion, HUVEC were grown to confluence in HUVEC medium on gelatincoated ( 1%) 96-well tissue culture plates (Costar Corp.) and then in RPMI 1640/10% BCS for 24 h before the study. Monolayers were washed once with 0.2 ml of PBS/ 1% BCS and were coincubated with 0.2 ml "' In-labeled PMN suspension (4 x 105 PMNs/well) in a humidified atmosphere containing 5% C02/95% air at 37°C. PMNs were allowed to settle for 10 min before the addition of agonists and then were coincubated with HUVEC monolayers for a further 30 min in the presence of agonists. Assays were terminated by removal of nonadherent cells by aspiration of medium and by washing of monolayers with 0.2 ml PBS/ 1% BCS. The contents of each well were solubilized with 0.01% SDS/0.025 N NaOH, and the radioactivity was measured in a gamma counter (Clinigamma; LKB Instruments, Inc.). The number of adherent PMNs (PMNs per square millimeter ofHUVEC monolayer) was calculated from the specific activity ofeach PMN preparation. For each experiment, LTB4-stimulated adhesion was calculated by subtraction of adhesion observed in the presence of diluent alone. PMN adhesion to adsorbed ICAM-1. ICAM-l was adsorbed overnight at 4°C onto 24-well tissue culture plates (Costar Corp.). Plates were then incubated with 1% human serum albumin at 37°C for a further 30 min. After aspiration, plates were treated with PBS containing 1% Tween for 2 min and were washed five times with PBS. "' In-labeled PMNs were added, were allowed to settle for 5 min, and then were incubated with LTB4 ( 10-7 M) (-I min at 12,000 g) through silicon oil (0.4 ml), and the radioactivity associated with cell pellets was determined in a scintillation counter, as described previously (26 4 .95±0.77%, n = 4, P < 0.001).
This system was used to determine the influence of 15(S)- ( 31 ) . This initial response was assessed as another index ofcytoskeletal reorganization in LTB4-stimulated PMNs and, in agreement with the assays of rhodamine-phalloidin staining, was inhibited after remodeling of PMNs with 15 (S)-HETE (Fig. 3) . These data suggest that esterified 15 Time (sec) Fig. 4, top) . Again, the magnitude of inhibition was significantly greater with 15(S)-HETE than with either 12(S)-HETE or 5(S)-HETE (Fig. 4, bottom) . LTB4 provokes CD 11/CD 18-mediated PMN-endothelial cell adhesion by increasing the avidity of CD 1 /CD 18 integrins for endothelial ligands, such as ICAM-1 (3, 34) . In keeping with these previous observations, LTB4-induced PMN adhesion and transmigration were inhibited by 65.0±1 1.0% and 42.6±14.0%, respectively, by anti-ICAM-l mAb (HuS/3; 25 jig/ml) in this study (n = 4). LTB4-stimulated PMN adhesion to ICAM-1 immobilized on plastic was monitored as an additional measure of CD 11/CD 18 avidity for cognate ligands. As with adhesion to HUVEC, PMN adhesion to adsorbed ICAM-1 was markedly inhibited after 15(S)-HETE remodeling of PMNs (Fig. 5) (Table I) .
(S)-HETE-remodeled
PMNs also generate an alternative profile of eicosanoids upon activation with chemoattractants, including increased LXA4 generation and reduced LTB4 synthesis ( 14) . The influence of LXA4 on LTB4-induced ( 10 -8 M, 30 min) transmigration was assessed to explore the possibil- (39) . The affinity ofthis receptor was reduced significantly after 15(S)-HETE remodeling of PMNs (Table III) .
LTB4-induced 1P3 generation was monitored to further define the influence of esterified 15(S)-HETE on receptor-triggered signal transduction events. LTB4 provoked a rapid increase in lP3 formation in vehicle-treated PMNs (Fig. 6, top) , as reported by other investigators (41) . IP3 levels were maximal after 5 s of exposure and declined to basal levels within 1 min (P3 levels in picomoles per 106 PMNs: basal 1.16±0.36; 5 s after LTB4 stimulation 2.42±0.41, n = 7, P < 0.001 ). Basal levels of IP3 were not different in 15 (S) -HETE-remodeled and vehicle-treated PMNs (not shown). In contrast, 15(S)-HETE-remodeled PMNs generated significantly less IP3 upon stimulation with LTB4 (35.3±11.8% inhibition, n = 7, P < 0.025; Fig. 6, bottom) . Taken together, these results suggest that 15 (S)-HETE remodeling causes striking downregulation ofthe LTB4 receptors that subserve PMN migration, and inhibition ofstimulus-response coupling with PMN cell membranes.
Discussion
Here, we present evidence that 15(S)-HETE is a potent and stereoselective inhibitor ofLTB4-stimulated PMN migration in vitro. This effect was dependent on esterification of 15(S)-HETE into PMN phospholipids, could be overcome by agents that bypass membrane signaling events, and was associated with a fivefold reduction in the affinity of specific PMN cellsurface receptors for LTB4. Importantly, 15(S)-HETE inhibited PMN transmigration at concentrations that are likely to be found in circulating blood during inflammation (17) . While our studies focused on the influence of 15 (S)-HETE on LTB4-induced PMN responses, it is noteworthy that 15(S)-HETE also blocked transmigration induced by C5a and FMLP and therefore may modulate the activity of other receptor-mediated stimuli for PMN recruitment during acute inflammation. These observations suggest a mechanism for the observed antiinflammatory activity of 15(S)-HETE in inflammatory diseases and support a role for 15(S)-HETE as a potential endogenous chalone which may serve to limit or reverse inflammation in vivo.
15 (S)-HETE is esterified rapidly into PMN phospholipids while uptake into other phospholipid classes, cholesterol ester, and triglycerides is < 4% (14) . In contrast, PMNs incorporate -0.6% of 5 (S)-HETE into phosphatidylinositol, -1.5% into phosphatidylcholine, and -0.8% into phosphatidylethanolamine, and -8% of added radiolabel is incorporated into triglycerides (14) . In the case of 12(S)-HETE, PMNs incorporate -2% into phosphatidylcholine, negligible amounts into other phospholipid classes, and -23% into triglycerides (29) . In this study 15 (S)-HETE was a significantly more potent inhibitor of transmigration than either 5(S)-HETE or 12(S)-HETE (Fig. 2) . These results suggest that the pattern of phospholipid remodeling is an important determinant in the action of 15 (S)-HETE on PMN transmigration and that remodeling of the inositol-containing phospholipid pool may be particularly important in this regard.
The inhibitory action of 15(S)-HETE proved stereoselective; 15(S)-HETE was significantly more potent than the Risomer as an inhibitor oftransmigration (Fig. 2) . 15 (Fig. 3) . Furthermore, treatment of PMNs with 15(5)-HETE also reduced the PMN right angle light scatter response induced by LTB4 (Fig. 3) , another index of cytoskeletal rearrangement (30, 31) . Several lines of evidence suggested that esterified 15(S)-HETE also blocked PMN transmigration by inhibiting PMN-endothelial cell adhesion mediated by interactions ofCD 11/ CD 1 8 integrins with endothelial cell ligands. Both transmigration and adhesion were CD 11 /CD1 8-dependent events, as determined by mAbblocking studies, and were attenuated dramatically by 15(S)-HETE. These responses also were inhibited by mAb against ICAM-1, suggesting that ICAM-1 was an important endothelial ligand for CDl 1/CD 18 under these conditions. Furthermore, 15 (S)-HETE, in addition to blocking PMN adhesion to endothelium, also blocked LTB4-stimulated adhesion ofPMNs to purified ICAM-1 (Fig. 5) . Interestingly, 15(5)-HETE did not prevent the rapid increase in CD 11 /CD 18 surface expression that occurs upon stimulation of PMNs with LTB4 (Fig. 5,  inset) . These observations provide further evidence that chemoattractants provoke CDll/CD18-mediated PMN adhesion, in large part, by increasing CD 11/CD 18 avidity rather than through changes in CD 1 /CD 18 surface expression (for review see reference 5). Furthermore, they suggest that these events may be mediated by different signal transduction pathways (vide infra).
Some 15 (S)-HETE is mobilized from esterified sites upon activation of PMNs and is transformed to other bioactive eicosanoids ( 14) . Other cell types, such as mast/basophil PT-18 cells, appear to express cell-surface receptors for 15 (S)-HETE (35) . The presence of putative 15 (S)-HETE-specific cell-surface receptors would be an attractive hypothetical site for 15(S)-HETE-evoked signaling responses. However, we were unable to demonstrate specific cell-surface binding sites for 15(S)-HETE with PMNs at 4°C (Table I) (37) . Furthermore, Hermanowski-Vosatka et al. (38) have recently demonstrated CD 1 /CD 18 modulatory activity in the lipids of activated PMNs. Alternatively, 15(S)-HETE could influence LTB4-induced adhesion and transmigration of PMNs by blocking LTB4-triggered signal transduction events. In the present study, A-23, 187 and PMA were useful pharmacologic tools for distinguishing among these possibilities in that they bypass receptor-ligand interactions. 15 (S)-HETE remodeling did not inhibit adhesion induced by either of these agonists, in marked contrast to its dramatic effects on LTB4-induced PMN-endothelial cell interactions (Table II) . These data provided compelling evidence that esterified 15(S)-HETE inhibits LTB4-induced adhesion by interfering with LTB4 signal transduction pathways within PMN cell membranes. Importantly, they also indicate that 15(S)-HETE-remodeled PMNs are viable and respond appropriately to stimuli which bypass initial signal transduction events.
Assessment ofspecific binding of [3H ] LTB4 (Table III) and LTB4-induced IP3 generation (Fig. 6 ) confirmed that 15(S)-HETE dramatically impairs stimulus-response coupling in PMN cell membranes. Concurrent with the reduction in CD 11/CD18-mediated PMN adhesion and transmigration, 15(S)-HETE remodeling caused a striking decrease in the affinity of the high affinity LTB4 cell-surface receptors that subserve these responses (39) . Furthermore, lP3 generation, a pivotal event in LTB4-triggered signal transduction events in PMN cell membranes (41 ) , was inhibited in 15 (S)-HETE-remodeled cells. The mechanism by which 15 (S)-HETE esterification modulates the affinity of LTB4 receptors can now be addressed in future studies. Interestingly, alterations in membrane lipid composition have been reported to alter the mobility of membrane-associated proteins (45) , to influence the conformation and/or density of many different receptors, and to modulate their accessibility and affinity for soluble ligands (37, (46) (47) (48) . Indeed, the omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid, also reduce the expression of LTB4 receptors on PMNs (49), a mechanism that may potentially account for their antiinflammatory activity in vivo.
Other cellular events that may potentially be modulated by esterified 15(S)-HETE and, thus, account for its inhibitory actions on LTB4-triggered PMN responses include LTB4 coupling to G-proteins, and activity of phospholipase C, actinbinding proteins, and PKC. Along these lines, it is intriguing to note that 15(S)-HETE-remodeled cells generate 15(S)-HETE-remodeled diacylglycerol (50) . Furthermore, arachidonate depletion impairs recognition ofboth phosphatidylinositol phosphate and bisphosphate by phospholipase C in pituitary GH3 cells (51 ) , and phosphatidylinositol phosphate and bisphosphate are important regulators of gelsolin, profilin, and several actin-binding proteins that modulate PMN actin assembly and motility (for review see references 2, 4).
In summary, the results of this study indicate that 15(5)-HETE remodeling of PMN phospholipids stereoselectively reduces the affinity of PMN LTB4 receptors for their cognate ligands and causes striking inhibition of LTB4-triggered stimulus-response coupling, cytoskeletal rearrangements, and PMN-endothelial cell interactions. These observations, when viewed in the context of the previously documented inhibitory actions of 15 (S)-HETE on PMN superoxide generation in vitro (52) and PMN-mediated inflammation in vivo (21, 22) , provide compelling evidence that 15 (S)-HETE may be an important endogenous inhibitor of inflammation. They raise the intriguing possibility that products of 5-lipoxygenase and 15-lipoxygenase pathways may exert counterbalancing modulatory influences on PMN trafficking, in a manner analogous to the opposing regulatory actions of the cyclooxygenase-derived products prostacyclin and thromboxane A2 on hemostasis and thrombosis. Further elucidation of the cellular and molecular actions of 1 
